Tysabri | eHealth Magazine

Say something

Tags: biotechnology, Disease, India, inflammation, Mississippi, MS, nervous system, Tysabri

Tysabri for the Treatment of Multiple Sclerosis

Biotechnology company Biogen Idec has announced the introduction of TYSABRI (natalizumab) the first humanized, monoclonal antibody for the treatment of relapsing remitting MS in India.

By Elets News Network

Government of India powers a population-scale vaccine drive on AWS

Amazon closes a $3.9 billion deal to acquire a primary-care clinic operator

Downturn impact: Healthtech startup MFine hands pink slip to over 500 employees

Transasia unveils a range of IVD solutions with enhanced user experience

AIIMS Jodhpur collaborates with Microsoft India to establish a Mixed Reality Center of Excellence

Tags: biotechnology, Disease, India, inflammation, Mississippi, MS, nervous system, Tysabri

Categories

Tysabri for the Treatment of Multiple Sclerosis

Corporate Updates

Government of India powers a population-scale vaccine drive on AWS

Amazon closes a $3.9 billion deal to acquire a primary-care clinic operator

Downturn impact: Healthtech startup MFine hands pink slip to over 500 employees

Transasia unveils a range of IVD solutions with enhanced user experience

AIIMS Jodhpur collaborates with Microsoft India to establish a Mixed Reality Center of Excellence

Flipkart Health+ App Launched

Subscribe To Our Newsletter

Medical Education

Digitisation is significantly boosting medical education and healthcare: Mansukh Mandaviya

Yogi proposes Rs 2,100 crore for medical colleges in 14 districts in UP budget

Yogi Government to introduce 5 new health-related courses to UP Skill Development Mission

UP government to complete construction of Atal Bihari Vajpayee Medical University in 2022

PM Modi: India to obtain a record number of new doctors in the next 10 years

Digital CME: Changing the Face of Learning

NEET UG is to be held in 14 cities abroad for the first time

Revolutionizing Healthcare Delivery: Striking the Virtual-Physical Balance

Healthcare innovations transforming patient experience: Purshottam Solanki, Dr. L H Hiranandani Hospital

Sustainable and Innovative Healthcare Infrastructure: HOSMAC's Journey and Vision

Tags: biotechnology, Disease, India, inflammation, Mississippi, MS, nervous system, Tysabri

document.write(currentDate);

Categories

Corporate Updates

Subscribe To Our Newsletter

Medical Education